Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway

Data ReadoutpositivePositive

AI Analysis

Summary

Bausch Health's Salix Pharmaceuticals announced positive results from a multicenter pilot study showing improved guideline adherence in cirrhosis management following implementation of a standardized clinical pathway.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Six-month pilot study demonstrated improved guideline adherence following implementation of standardized cirrhosis clinical pathway

Importance:4/10

Sentiment:

0.60

gastroenterologycirrhosisclinical pathwayguideline adherencepilot study

Related Companies

$BHC

Read the original article

Published by PR Newswire Biotech on October 12, 2026 12:00 PM

Read Original